In earlier studies, the expansion rate of atrophy ranged from 0.31 to 0.57 mm/year in eyes treated with anti-VEGF agents [23,24,26,27], and the expansion rate was 0.21 to 0.58 mm/year without anti-VEGF treatment [28,29,30,31]. Here, VEGFA is linked to Atrophy.